• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.82% Nasdaq Up2.46%

    Echo Therapeutics, Inc. (ECTE)

    -NasdaqCM
    1.47 Down 0.03(2.00%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 57   28   5  
    Cost of Revenue -   -   -  
    Gross Profit 57   28   5  
    Operating Expenses
    Research Development4,962  12,992  8,671  
    Selling General and Administrative7,415  6,681  6,374  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (12,320) (19,645) (15,040)
    Income from Continuing Operations
    Total Other Income/Expenses Net913  4,481  3,213  
    Earnings Before Interest And Taxes(11,407)(15,164)(11,827)
    Interest Expense3,551  3,903  505  
    Income Before Tax(14,959)(19,067)(12,332)
    Income Tax Expense4   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(14,963)(19,067)(12,332)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (14,963) (19,067) (12,332)
    Preferred Stock And Other Adjustments(350)(371) -  
    Net Income Applicable To Common Shares (15,313) (19,439) (12,332)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.